Splenic B-cell marginal zone lymphoma with marked plasmocytic differentiation: tumor variant from Mott cells?
https://doi.org/10.17650/1818-8346-2015-10-4-34-37
Abstract
Splenic B-cell marginal zone lymphoma (SMZL) – a rare B-cell non-Hodgkin, s lymphoma, which is represented morphologically by mature lymphoid cells, corresponding to lymphocytes of secondary follicles marginal zone by immunological characteristics. Plasma cell differentiation can be in marginal zone lymphoma, but we described a single case of abundance of Mott cells as a tumor substrate in splenic B-cell marginal zone lymphoma.
We present the first case of SMZL represented by Mott cells. This was the second case of Mott cells tumor described in Russia.
This observation is the only case among the collected material of splenic lymphomas. The morphological pattern is characterized by marked proliferation of monoclonal lymphoid cells with plasma cell differentiation with presence of Mott cells and is evidence of intense intracellular secretion of immunoglobulins.
About the Authors
U. L. Julhakyan
National Research Center for Hematology, Ministry of Health of Russia
Russian Federation
4 Novyy Zykovskiy Proezd, Moscow,125167
Russian Federation
4 Novyy Zykovskiy Proezd, Moscow,125167
V. N. Dvirnyk
National Research Center for Hematology, Ministry of Health of Russia
Russian Federation
4 Novyy Zykovskiy Proezd, Moscow,125167
Russian Federation
4 Novyy Zykovskiy Proezd, Moscow,125167
L. P. Mendeleeva
National Research Center for Hematology, Ministry of Health of Russia
Russian Federation
4 Novyy Zykovskiy Proezd, Moscow,125167
Russian Federation
4 Novyy Zykovskiy Proezd, Moscow,125167
References
1. Russell W. An address on a characteristic organism of cancer. Br Med J 1890;2(1563):1356–60.
2. Russell W. The parasite of cancer. Lancet 1899;1:1138–41.
3. Alanen A., Pira U., Lassila O. et al. Mott cells are plasma cells defective in immunoglobulin secretion. Eur J Immunol 1985;15(3):235–42.
4. Valetti C., Grossi C.E., Milstein C. et al. Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum. J Cell Biol 1991;115:983–94.
5. van der Twell T.G., Taylor C.R., Parker J.W. Immunoglobulin inclusion in non-Hodgkin,s lymphomas. Am J Clin Pathol 1978;69:306–13.
6. Gebbers J.O., Otto H.F. Plasma cell alterations in ulcerative colitis. An electron microscopic study. Pathol Eur 1976; 11:271–9.
7. Gray A., Doniach I. Ultrastructure of plasma cell containing Russell bodies in human stomach and thyroid. J Clin Pathol 1970;23:608–12.
8. Posnett D.N., Mouradian J., Mangraviti D.J., Wolf D.J. Mott cells in a patient with a lymphoproliferative disorder. Differentiation of a clone of B-lymphocytes into Mott cells. Am J Med 1984;77(1):125–30.
9. Blom J., Mansa B., Wilk A. A study of Russell bodies in human monoclonal plasma cells by means of immunofluorescence and electron microscopy. Acta Pathol Microbiol Scand A 1976;84(4):335–49.
10. El-Okda M., Hyeh Y., Xie S.S., Hsu S.M. Russell bodies consist of heterogenous glycoproteins in B-cell lymphoma cells. Am J Clin Pathol 1992;97:866–71.
11. Kurihara K., Sakai H., Hashimoto N. Russell body-like inclusions in oral B-lymphomas. J Oral Pathol 1984;13:640–9.
12. Mott F. Observations on the brains of men and animals infected with various forms of trypanosomes. Preliminary note. Proc Royal Soc London B 1905;76: 235–42.
13. Rondanelli E.G., Gorini P., Strosselli E., Pecorari D. The nature of the endocytoplasmic globules of the morular cells of human bone marrow. Haematologica 1957;42(8):1027–40.
14. Jacob H., Lutcke A. Subacute sclerosing leukoencephalitis simulating acute epidemic encephalitis (acute encephalitic parkinsonism) with marked development of morular cells and Russell bodies. J Neurol Sci 1971;12(2):137–53.
15. Greenwood B.M., Whittle H.C. Cerebrospinal fluid IgM in patients with sleeping sickness. Lancet 1973;2(7828):525–7.
16. Alanen A., Pira U., Lassila O. et al. Mott cells are plasma cells defective in immunoglobulin secretion. Eur J Immunol 1985;15:235–42.
17. Navas-Palacios J.J., Valdes LahuertaPalacios J.J. Signet-Ring cell lymphoma. Ultrastructural and immunohistochemical features of three varieties. Cancer 1983;52:1613–23.
18. Jack H.M., Beck-Engeser G., Sloant B. et al. A different sort of Mott cell. Proc Natl Acad Sci USA 1992;89(24):11688–91.
19. Paik S., Kim S.H., Kim J.H. et al. Russell body gastritis associated with Helicobacter pylori infection: a case report. J Clin Pathol 2006;59:1316–9.
20. Кокосадзе Н.В., Ковригина А.М., Пробатова Н.А. MALT-лимфома желудка с выраженной плазмоцитарной дифференцировкой: вариант опухоли из клеток Мотта. Архив патологии 2004;66(5):40–2. [Kokosadze N.V., Kovrigina A.M., Probatova N.A. MALT-lymphoma of the stomach with marked plasmocytic differentiation: a variant of mott cells tumor. Archiv patologii = Archives of Pathology 2004;66(5):40–2. (In Russ.)].
21. Джулакян У.Л., Гриншпун Л.Д. Селезеночная лимфома из клеток маргинальной зоны (лимфомоцитома селезенки) у пожилых пациентов: клиника, диагностика, лечение. В кн.: Гериатрическая гематология. Заболевания системы крови в старших возрастных группах. Под ред. Л.Д. Гриншпун, А.В. Пивника. М., 2012. [Dzhulakyan U.L., Grinshpun L.D. Splenic lymphoma form marginal zone cells (spleen lymphocytoma) in elderly patients: clinical features, diagnosis, treatment. In: Geriatric hematology. Blood diseases in the elderly patients. Ed. by: L.D. Grinshpun, A.V. Pivnik. Moscow, 2012. Pp. 237–44. (In Russ.)].
22. Джулакян У.Л. Лимфоцитома селезенки (лимфома из клеток маргинальной зоны селезенки): диагностика, лечение. Автореф. дис. … канд. мед. наук. М., 2011. [Dzhulakyan U.L. Spleen lymphocytoma (lymphoma from splenic marginal zone cells): diagnosis and treatment. Author, s abstract of thesis … of candidate of medical scienses. Moscow, 2011. (In Russ.)].
23. Isaacson P.G., Piris M.A. Splenic marginal zone lymphoma. Adv Anat Pathol 1997;4:191–201.
24. Franco V., Florena A.M., Campesi G. Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma. Histopathology 1996;29:571–5.
25. Силаев М.А., Карагюлян С.Р., Буланов А.Ю. и др. Спленэктомия при массивной и гигантской спленомегалии. Гематология и трансфузиология 2011;56(1):6–10. [Silaev M.A., Karagyulyan S.R., Bulanov A.Yu. et al. Splenectomy in massive and giant splenomegaly. Gematologiya i transfuziologiya = Hematology and Transfusiology 2011;56(1):6–10. (In Russ.)].
26. Julhakyan H., Grjimolovskiy A., Karagulyan S. et al. Treatment of splenic marginal zone lymphoma. Haematologica 2010;95(2):622.
27. Julhakyan U., Magomedova A., Kravchenko S. et al. Splenic marginal zone lymphoma: characteristics and treatment. Haematologica 2011;96(2):393–4.
28. Hussong J.W., Perkins S.L., Schnitzer B. et al. Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol 1999;111(1):111–6.
Review
For citations:
Julhakyan U.L., Dvirnyk V.N., Mendeleeva L.P. Splenic B-cell marginal zone lymphoma with marked plasmocytic differentiation: tumor variant from Mott cells? Oncohematology. 2015;10(4):34-37. (In Russ.) https://doi.org/10.17650/1818-8346-2015-10-4-34-37
Views:
10791
Email this article 